Free Trial

Aptevo Therapeutics (APVO) Competitors

Aptevo Therapeutics logo
$3.10 +0.20 (+6.90%)
Closing price 04:00 PM Eastern
Extended Trading
$3.02 -0.08 (-2.58%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

APVO vs. APRE, GTBP, DWTX, KPRX, AEON, LSB, TCRT, SNPX, CHRO, and TSBX

Should you be buying Aptevo Therapeutics stock or one of its competitors? The main competitors of Aptevo Therapeutics include Aprea Therapeutics (APRE), GT Biopharma (GTBP), Dogwood Therapeutics (DWTX), Kiora Pharmaceuticals (KPRX), AEON Biopharma (AEON), LakeShore Biopharma (LSB), Alaunos Therapeutics (TCRT), Synaptogenix (SNPX), Chromocell Therapeutics (CHRO), and Turnstone Biologics (TSBX). These companies are all part of the "pharmaceutical products" industry.

Aptevo Therapeutics vs. Its Competitors

Aptevo Therapeutics (NASDAQ:APVO) and Aprea Therapeutics (NASDAQ:APRE) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

Aptevo Therapeutics has a net margin of 0.00% compared to Aprea Therapeutics' net margin of -1,095.02%. Aprea Therapeutics' return on equity of -68.39% beat Aptevo Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Aptevo TherapeuticsN/A -779.42% -175.59%
Aprea Therapeutics -1,095.02%-68.39%-55.74%

8.1% of Aptevo Therapeutics shares are held by institutional investors. Comparatively, 34.2% of Aprea Therapeutics shares are held by institutional investors. 0.1% of Aptevo Therapeutics shares are held by insiders. Comparatively, 13.6% of Aprea Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Aprea Therapeutics has lower revenue, but higher earnings than Aptevo Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aptevo Therapeutics$3.11M0.76-$24.13MN/AN/A
Aprea Therapeutics$1.50M6.64-$12.96M-$2.37-0.76

In the previous week, Aptevo Therapeutics had 2 more articles in the media than Aprea Therapeutics. MarketBeat recorded 2 mentions for Aptevo Therapeutics and 0 mentions for Aprea Therapeutics. Aptevo Therapeutics' average media sentiment score of 0.00 equaled Aprea Therapeutics'average media sentiment score.

Company Overall Sentiment
Aptevo Therapeutics Neutral
Aprea Therapeutics Neutral

Aptevo Therapeutics presently has a consensus price target of $219,040.00, suggesting a potential upside of 7,065,706.45%. Aprea Therapeutics has a consensus price target of $15.50, suggesting a potential upside of 761.11%. Given Aptevo Therapeutics' higher probable upside, research analysts clearly believe Aptevo Therapeutics is more favorable than Aprea Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aptevo Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Aprea Therapeutics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Aptevo Therapeutics has a beta of 5.58, indicating that its share price is 458% more volatile than the S&P 500. Comparatively, Aprea Therapeutics has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500.

Summary

Aprea Therapeutics beats Aptevo Therapeutics on 7 of the 12 factors compared between the two stocks.

Get Aptevo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APVO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APVO vs. The Competition

MetricAptevo TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.19M$2.88B$5.47B$8.95B
Dividend YieldN/A2.46%5.25%4.06%
P/E RatioN/A20.8027.0020.10
Price / Sales0.76286.98435.75120.29
Price / CashN/A41.1936.8257.86
Price / Book0.057.487.985.56
Net Income-$24.13M-$55.04M$3.16B$248.40M
7 Day Performance5.08%5.44%3.69%6.04%
1 Month Performance-37.37%2.38%2.91%7.69%
1 Year Performance-99.96%5.53%34.30%20.97%

Aptevo Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APVO
Aptevo Therapeutics
2.0988 of 5 stars
$3.10
+6.9%
$219,040.00
+7,065,706.5%
-100.0%$2.19M$3.11M0.0050
APRE
Aprea Therapeutics
2.5035 of 5 stars
$1.69
+0.9%
$15.50
+817.2%
-55.4%$9.27M$1.50M-0.717
GTBP
GT Biopharma
1.3975 of 5 stars
$3.58
+1.1%
$11.00
+207.3%
-24.7%$9.16MN/A-0.638
DWTX
Dogwood Therapeutics
1.1519 of 5 stars
$4.77
+1.3%
$10.00
+109.6%
N/A$9MN/A-0.265Positive News
KPRX
Kiora Pharmaceuticals
2.2638 of 5 stars
$2.88
-0.7%
$10.00
+247.2%
-38.8%$8.83M$16.02M-0.9910Positive News
AEON
AEON Biopharma
3.3459 of 5 stars
$0.76
+0.1%
$360.00
+47,268.4%
-98.9%$8.59MN/A4.225
LSB
LakeShore Biopharma
0.3436 of 5 stars
$1.02
+11.0%
N/AN/A$8.55M$80.82M0.00773News Coverage
Positive News
Gap Up
High Trading Volume
TCRT
Alaunos Therapeutics
0.4887 of 5 stars
$4.85
-5.5%
N/A-21.3%$8.41M$10K-1.9140
SNPX
Synaptogenix
1.1525 of 5 stars
$7.85
+29.8%
$14.00
+78.3%
+106.8%$8.40MN/A-0.784High Trading Volume
CHRO
Chromocell Therapeutics
N/A$1.26
-6.7%
N/A-89.1%$8.31MN/A-1.024Gap Up
TSBX
Turnstone Biologics
1.5663 of 5 stars
$0.36
+1.8%
$0.45
+25.3%
-83.7%$8.16M$19.31M-0.1382High Trading Volume

Related Companies and Tools


This page (NASDAQ:APVO) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners